Invention Grant
- Patent Title: Genetically modified cell and process for use of said cell
- Patent Title (中): 用于所述细胞的转基因细胞和方法
-
Application No.: US14003386Application Date: 2012-03-07
-
Publication No.: US09309546B2Publication Date: 2016-04-12
- Inventor: Nick Johannes Petrus Wierckx , Tom Daniel Elink Schuurman , Sipko Maarten Kuijper , Harald Johan Ruijssenaars
- Applicant: Nick Johannes Petrus Wierckx , Tom Daniel Elink Schuurman , Sipko Maarten Kuijper , Harald Johan Ruijssenaars
- Applicant Address: NL Gorinchem
- Assignee: Purac Biochem B.V.
- Current Assignee: Purac Biochem B.V.
- Current Assignee Address: NL Gorinchem
- Agency: Bozicevic, Field & Francis LLP
- Agent Bret E. Field
- Priority: NL2006359 20110308
- International Application: PCT/NL2012/050141 WO 20120307
- International Announcement: WO2012/064195 WO 20120518
- Main IPC: C07K14/195
- IPC: C07K14/195 ; C12P17/04 ; C12N9/02
Abstract:
The present invention relates to the field of biotransformation of furanic compounds. More particular the present invention relates to novel genetically modified cells with improved characteristics for biocatalytic transformation of furanic compounds and a vector suitable for the genetic modification of a host cell. Further aspects of the invention are aimed at processes for biotransformation of 5-(hydroxymethyl)furan-2-carboxylic acid (HMF-acid) and its precursors with the use of the cell according to the invention.
Public/Granted literature
- US20140073019A1 GENETICALLY MODIFIED CELL AND PROCESS FOR USE OF SAID CELL Public/Granted day:2014-03-13
Information query
